Cited by 264Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanismsNeurological Disease Mechanisms and Treatments

Differential migration, LPS‐induced cytokine, chemokine, and NO expression in immortalized BV‐2 and HAPI cell lines and primary microglial cultures

Open access
Horvath, Ryan J., Nutile‐McMenemy, Nancy, Alkaitis, Matthew S., DeLeo, Joyce A.·2008·Journal of Neurochemistry

Abstract

Microglial cells are hematopoietically derived monocytes of the CNS and serve important neuromodulatory, neurotrophic, and neuroimmune roles. Following insult to the CNS, microglia develop a reactive phenotype, migrate to the site of injury, proliferate, and release a range of proinflammatory, anti‐inflammatory, and neurotrophic factors. Isolation of primary microglial cell cultures has been an integral step in elucidating the many roles of these cells. In addition to primary microglial cells, several immortalized cell lines have been created to model primary microglia in vitro, including murine‐derived BV‐2 cells and rat derived highly aggressive proliferating immortalized (HAPI) cells. Here, we compare rat primary microglial, BV‐2, and HAPI cells in experiments assessing migration, expression of activation markers, and production and release of nitric oxide, cytokines, and chemokines. BV‐2 and HAPI cells responded similarly to primary microglia in experiments assessing migration, ionized calcium binding adaptor molecule 1 expression, and nitric oxide release. However, BV‐2 and HAPI cells did not model primary microglia in experiments assessing tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, and monocyte chemoattractant protein‐1 expression and release and phospho‐extracellular signal‐regulated kinase 44/42 expression following lipopolysaccharide treatment. These results indicate that BV‐2 and HAPI cell cultures only partially model primary microglia and that their use should therefore be carefully considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2008.05633.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Differences between immortalized cell lines and primary murine microglia are not insignificant.

    “However, several reports have indicated that differences between immortalized cell lines and primary murine microglia are not insignificant [83,84].”

    From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [83]

    The Discussion reports substantial differences between the immortalized BV-2 and HAPI lines and primary microglia, particularly in inflammatory responses. However, the Abstract specifies that the primary cultures tested were rat, not murine; the source therefore does not directly establish the claim for primary murine microglia. Page numbers were not provided in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • BV-2 cells show damped cytokine release compared to primary microglia, while responding similarly in migration and activation experiments.

    “In particular, while BV-2 and primary microglia respond similarly in migration and activation experiments, BV-2 cells show a damped cytokine release [83].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results Clin Neuropharmacol 2008 31 141 150 18520981 PMC4372145
  2. Bath PM Bath-Hextall FJ Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke Cochrane Database Syst Rev 2004, CD000162. 15266424
  3. Blasi E Barluzzi R Bocchini V Mazzolla R Bistoni F Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus J Neuroimmunol 1990 27 229 237 2110186
  4. Blum D Chtarto A Tenenbaum L Brotchi J Levivier M Clinical potential of minocycline for neurodegenerative disorders Neurobiol Dis 2004 17 359 366 15571972
  5. Boje KM Arora PK Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death Brain Res 1992 587 250 256 1381982
  6. Bonelli RM Hodl AK Hofmann P Kapfhammer HP Neuroprotection in Huntington’s disease: a 2-year study on minocycline Int Clin Psychopharmacol 2004 19 337 342 15486519
  7. Brautigam VM Frasier C Nikodemova M Watters JJ Purinergic receptor modulation of BV-2 microglial cell activity: potential involvement of p38 MAP kinase and CREB J Neuroimmunol 2005 166 113 125 15979729
  8. Cheepsunthorn P Radov L Menzies S Reid J Connor JR Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain Glia 2001 35 53 62 11424192
  9. de Jong EK de Haas AH Brouwer N Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3 J Neurochem 2008 18248618
  10. DeLeo JA Yezierski RP The role of neuroinflammation and neuroimmune activation in persistent pain Pain 2001 90 1 6 11166964
  11. Frampton M Harvey RJ Kirchner V Propentofylline for dementia Cochrane Database Syst Rev 2003, CD002853. 12804440
  12. Furtner T Zierler S Kerschbaum HH Blockade of chloride channels suppresses engulfment of microspheres in the microglial cell line, BV-2 Brain Res 2007 1184 1 9 17991458
  13. Giulian D Baker TJ Characterization of ameboid microglia isolated from developing mammalian brain J Neurosci 1986 6 2163 2178 3018187 PMC6568755
  14. Gordon PH Moore DH Miller RG Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial Lancet Neurol 2007 6 1045 1053 17980667
  15. Hanisch UK Kettenmann H Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nat Neurosci 2007 10 1387 1394 17965659
  16. Hausler KG Prinz M Nolte C Weber JR Schumann RR Kettenmann H Hanisch UK Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages Eur J Neurosci 2002 16 2113 2122 12473079
  17. He BP Wen W Strong MJ Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro J Neuroimmunol 2002 128 31 38 12098508
  18. Jantaratnotai N Utaisincharoen P Piyachaturawat P Chongthammakun S Sanvarinda Y Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia Life Sci 2006 78 571 577 16107265
  19. Kittner B De Deyn PP Erkinjuntti T Investigating the natural course and treatment of vascular dementia and Alzheimer’s disease. Parallel study populations in two randomized, placebo-controlled trials Ann N Y Acad Sci 2000 903 535 541 10818549
  20. Kloss CU Bohatschek M Kreutzberg GW Raivich G Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture Exp Neurol 2001 168 32 46 11170719
  21. Kremlev SG Palmer C Interleukin-10 inhibits endotoxin-induced proinflammatory cytokines in microglial cell cultures J Neuroimmunol 2005 162 71 80 15833361
  22. Kremlev SG Roberts RL Palmer C Differential expression of chemokines and chemokine receptors during microglial activation and inhibition J Neuroimmunol 2004 149 1 9 15020059
  23. Muccioli GG Xu C Odah E Cudaback E Cisneros JA Lambert DM Lopez Rodriguez ML Bajjalieh S Stella N Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells J Neurosci 2007 27 2883 2889 17360910 PMC6672592
  24. Nutile-McMenemy N Elfenbein A Deleo JA Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression J Neurochem 2007 103 2035 2046 17868321
  25. Raouf R Chabot-Dore AJ Ase AR Blais D Seguela P Differential regulation of microglial P2×4 and P2×7 ATP receptors following LPS-induced activation Neuropharmacology 2007 53 496 504 17675190
  26. Ringheim GE Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer’s disease and vascular dementia Ann N Y Acad Sci 2000 903 529 534 10818548
  27. Romero-Sandoval A Eisenach JC Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision Anesthesiology 2007 106 787 794 17413917
  28. Seabrook TJ Jiang L Maier M Lemere CA Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice Glia 2006 53 776 782 16534778
  29. Stohwasser R Giesebrecht J Kraft R Muller EC Hausler KG Kettenmann H Hanisch UK Kloetzel PM Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide Glia 2000 29 355 365 10652445
  30. Streit WJ Walter SA Pennell NA Reactive microgliosis Prog Neurobiol 1999 57 563 581 10221782
  31. Tsuda M Shigemoto-Mogami Y Koizumi S Mizokoshi A Kohsaka S Salter MW Inoue K P2×4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 2003 424 778 783 12917686
  32. Watters JJ Sommer JA Pfeiffer ZA Prabhu U Guerra AN Bertics PJ A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production J Biol Chem 2002 277 9077 9087 11786532
  33. Xu Q Li Y Cyras C Sanan DA Cordell B Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle J Biol Chem 2000 275 31770 31777 10918055
  34. Zhang Z Zhang ZY Fauser U Schluesener HJ Mechanical allodynia and spinal up-regulation of P2×(4) receptor in experimental autoimmune neuritis rats Neuroscience 2008 152 495 501 18276080
  35. Zierler S Frei E Grissmer S Kerschbaum HH Chloride influx provokes lamellipodium formation in microglial cells Cell Physiol Biochem 2008 21 55 62 18209472
  36. Zuckerman SH Evans GF Snyder YM Roeder WD Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression J Immunol 1989 143 1223 1227 2501392

Cited by

Sorted by citations

Authors
Horvath, R. J., Nutile‐McMenemy, N., Alkaitis, M. S., & DeLeo, J. A.
Affiliations
Dartmouth College (US)
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2008-10
Volume
107
Issue
2
Pages
557-569
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1509256585
Cited by
264
References
1
Citations by year
2026: 8 · 2025: 10 · 2024: 13 · 2023: 11 · 2022: 25 · 2021: 24 · 2020: 16 · 2019: 11 · 2018: 21 · 2017: 13 · 2016: 11 · 2015: 17 · 2014: 12 · 2013: 17 · 2012: 17
FWCI
8.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Drug Abuse (DA 11276, R01DA011276)
  • National Institute of Allergy and Infectious Diseases (T32AI07363, T32AI007363)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR44757, R01AR044757)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
microglia, BV-2 cells, microglial migration, lipopolysaccharide, neuroinflammation, nitric oxide, cytokines, chemokines, TNF-α, IL-1β, interleukin-6, MCP-1, ERK1/2 phosphorylation, Iba1
MeSH terms
Animals, Animals, Newborn, Calcium-Binding Proteins, Cell Movement, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Lipopolysaccharides, Microfilament Proteins, Minocycline, Nitric Oxide, Time Factors, Xanthines, Cytokines, Microglia, Neuroprotective Agents, Extracellular Signal-Regulated MAP Kinases, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review